# Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients

> **NCT05395429** · — · UNKNOWN · sponsor: **Genetron Health** · enrollment: 1000 (estimated)

## Conditions studied

- Thyroid Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05395429
- **Lead sponsor:** Genetron Health
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-25
- **Primary completion:** 2023-11-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05395429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05395429, "Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05395429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*